IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Medico Remedies IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 10.99 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Aryaman Financial Services is the merchant banker of Medico Remedies IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 28th September 2017.
Medico Remedies IPO posted revenues of ₹ 59.52 crores and PAT of ₹ 0.80 crores in FY18 on annualised basis.
Revenue:
₹ 58.54 Cr.
EBITDA Margin:
7.00
% 
Net Worth: ₹ 16.77 Cr.
Market Capitalisation:
[●]
P/E:
52.00 times
P/BV: [●]
EV/EBITDA: [●]
Financial results of Medico Remedies IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-17 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 48.59 | 48.24 | 45.54 | 35.74 | |
| Net Worth | 16.77 | 16.37 | 14.74 | 13.61 | |
| Total Debt | 18.41 | 18.49 | 13.79 | 7.88 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
29.27
58.54 |
54.41 | 66.68 | 50.98 | |
EBITDA
EBITDA on annualised basis |
2.05
4.10 |
4.35 | 3.89 | 3.01 | |
PAT
PAT on annualised basis |
0.40
0.80 |
1.62 | 1.12 | 0.79 | |
Medico Remedies IPO PAT Margin is 1.37 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Medico Remedies IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-17 | FY17 | FY16 | FY15 |
|---|---|---|---|---|
| EBITDA Margin (%) | 7.00 | 7.99 | 5.83 | 5.90 |
| PAT Margin (%) | 1.37 | 2.98 | 1.68 | 1.55 |
| EPS (₹) | 1.25 | 5.09 | 3.53 | 2.69 |
| ROE (%) | 2.39 | 9.90 | 7.60 | 5.80 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 0.82 | 3.36 | 2.46 | 2.21 |
| Debt to Equity | 1.10 | 1.13 | 0.94 | 0.58 |
The market Capitalisation of Medico Remedies IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Medico Remedies IPO prospectus highlights an Return on Equity (ROE) of 2.39 % , Return on Assets (ROA) of 0.82 %, and an EBITDA Margin of 7.00 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Medico Remedies IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Medico Remedies IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Medico Remedies IPO has a Price-to-Earnings (PE) ratio of 52.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Medico Remedies IPO reported revenue of ₹ 59.52 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Medico Remedies IPO provide insights into sales growth, market demand, and business scalability.
Medico Remedies recorded an EBITDA of ₹ 4.10 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Medico Remedies Profit After Tax (PAT) is ₹ 0.80 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 58.54 Cr.
EBITDA Margin:
7.00
%
Net Worth: ₹ 16.77 Cr.
Market Capitalisation:
[●]
P/E:
52.00 times
P/BV: [●]
EV/EBITDA: [●]
Medico Remedies operates in Pharmaceutical and Manufacturing And Selling Of Pharmaceutical Formulation Products In India.. The Issue is listed on BSE SME in Feb, 2018. Medico Remedies IPO size was 10.99 with Issue price of 100.00 .
Merchant Banker(s) of Medico Remedies IPO: Aryaman Financial Services Limited
Medico Remedies IPO subscription was 1.84 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Medico Remedies IPO listed at a listing price of 97.15 against the offer price of 100.00.
The current market price of Medico Remedies is 49.00.
Why Us?
